Paxata Data Prep Platform Certified on Cloudera Enterprise for Comprehensive Platform Support With Enterprise-Grade Security and Controls

REDWOOD CITY, Calif., Sept. 23, 2015 (GLOBE NEWSWIRE) — Paxata, provider
of the only Adaptive Data Preparation™ platform for the enterprise, in partnership
with Cloudera, the leader in enterprise analytic data management powered
by Apache Hadoop™, today announced the certification of its data preparation
platform on Cloudera Enterprise 5 through the Cloudera Certified Technology
Program (CCTP).

Paxata Data Prep Platform Certified on Cloudera Enterprise for Comprehensive Platform Support With Enterprise-Grade Security and Controls Read More »

MerLion’s Finafloxacin Shown to be More Efficacious than Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections

Singapore, 20 September 2015 – MerLion Pharmaceuticals (“MerLion”) today presented detailed
data from its Phase 2 study in patients hospitalized with complicated urinary tract infections (cUTI)
and pyelonephritis showing that a five day course of its novel antibacterial, finafloxacin, was more
effective than treatment with the current standard of care (ciprofloxacin).

MerLion’s Finafloxacin Shown to be More Efficacious than Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections Read More »

QT Vascular Announces CE Mark Clearance of Chocolate Touch by LRQA 0088

SINGAPORE, 7 September 2015 – QT Vascular Ltd., together with its subsidiaries (the
“Company” or “QT Vascular”, and together with its subsidiaries, the “Group”), a global company
engaged in the design, assembly and distribution of advanced therapeutic solutions for the
minimally invasive treatment of vascular disease, announced today that has received CE mark
clearance for its unique peripheral drug-coated balloon, Chocolate® Touch. The CE mark was
granted by Lloyds Register Quality Assurance Notified Body Number 0088 (“LRQA 0088”).

QT Vascular Announces CE Mark Clearance of Chocolate Touch by LRQA 0088 Read More »

Rapid Micro Biosystems Announces the Commercial Availability of the Growth Direct(TM) MultiTest System

LOWELL, Mass., Sept. 01, 2015 (GLOBE NEWSWIRE) — Rapid Micro Biosystems,
the provider of automated, rapid, non-destructive detection and enumeration
technologies in microbiology, today announced the continued expansion of the
Growth Direct™ product line with the launch of the Growth Direct MultiTest
System.

Rapid Micro Biosystems Announces the Commercial Availability of the Growth Direct(TM) MultiTest System Read More »

QT Vascular’s Revenue Grows 9% to US$6.6M in 1H2015

SINGAPORE, 12 August 2015 – QT Vascular Ltd., together with its subsidiaries (“QT Vascular”
or the “Group”), a global company engaged in the design, assembly and distribution of advanced
therapeutic solutions for the minimally invasive treatment of vascular disease, reported a 8.9%
increase in revenue to US$6.6 million for the first six months ended 30 June 2015 (“1H2015”),
from US$6.1 million a year ago with net loss attributable to shareholders narrowing 47.2% to
US$12.0 million from US$22.7 million. Gross profit margin for 1H2015 improved to 32.3% from
8.6% previously.

QT Vascular’s Revenue Grows 9% to US$6.6M in 1H2015 Read More »

Enlighted Expands to Mexico

SUNNYVALE, Calif., Aug. 12, 2015 /PRNewswire/ — Enlighted, Inc., the leading
provider of Internet of Things (IoT) solutions for commercial buildings, today
announced the expansion of its global operations in Mexico, in close collaboration
with its distribution partner, Yolk Soluciones Creativas, an affiliate of Grupo Asercom,
an ISO 20000 certified company with more than 26 years of experience in energy,
smart home and IT solutions.

Enlighted Expands to Mexico Read More »

Rapid Micro Biosystems Expands Series C Round with Investment from EDBI

马萨诸塞州,洛威尔 – 2015 年 8 月 11 日 -自动化、非破坏性、快速微生物侦测的领先
供应商 Rapid Micro Biosystems 今日宣布获得新加坡经济发展局投资机构 EDBI 的投资,
加大了公司最近展开的 C 轮融资。这次的投资将用做扩展其支持 Rapid Micro
Biosystems Growth Direct™ 环球商务与制造运营的业务。R

Rapid Micro Biosystems Expands Series C Round with Investment from EDBI Read More »